GoodRx Holdings, Inc. Quarterly Costs and Expenses in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
GoodRx Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2019 to Q2 2024.
  • GoodRx Holdings, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $181M, a 5.46% increase year-over-year.
  • GoodRx Holdings, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $804M, a 10.3% increase year-over-year.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2023 was $777M, a 1.63% increase from 2022.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2022 was $765M, a 4.48% increase from 2021.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2021 was $732M, a 11.4% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $804M $181M +$9.36M +5.46% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $795M $190M +$17.8M +10.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $777M $215M +$32.6M +17.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $745M $218M +$15.3M +7.52% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $729M $171M -$24.5M -12.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $754M $173M -$10.9M -5.93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $765M $182M -$19.1M -9.49% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $784M $203M +$14.9M +7.94% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $769M $196M +$18.9M +10.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $750M $184M +$18.1M +11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $732M $202M -$251M -55.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $984M $188M -$14M -6.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $998M $177M +$95.4M +117% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $902M $165M +$75.7M +84.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $826M $453M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $202M +$138M +216% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $81.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $89.7M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 $63.9M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.